Patanjali doesn't want to share benefits of centuries-old medicine system

Ramdev's corporate behemoth Patanjali's claim that Indian firms do not have to share benefits for using bio resources is troubling

Pressed for sharing

The Uttarakhand high court order on Ramdev's firm to pay for use of bioresources has put herbal companies on notice

Patanjali judgement can have ramifications beyond Uttarakhand

NBA sources say many big players in the industry have not yet registered with biodiversity boards

Ramdev shouldn’t criticise other systems of medicine: SC

Reply sought from Patanjali, Centre over Indian Medical Association plea; Experts say time to update Ayurveda textbooks

How companies got their way on biodiversity

Amendments to the Biodiversity Act let companies off the hook on having to share the benefits of using biological resources

Simply Put: Patanjali’s magic COVID-19 pills

COVID-19: Patanjali drugs get go-ahead from govt but key questions unanswered

AYUSH ministry says drugs only for immunity, Patanjali claims patients’ recovery

Many links missing in Patanjali’s claims of COVID-19 drugs

AYUSH ministry halts sales but experts question other government agencies too